Childhood Atopic Dermatitis Not Linked to Cardiovascular Risk in Early Adulthood The American Journal of Managed Care® (AJMC®) Source link
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities The Globe and Mail Source link
Kymera’s STAT6 Degrader for Inflammatory Disease Shows Early Success in Phase I Genetic Engineering and Biotechnology News Source link
Diverse, Nutritious Early Diet May Ease Childhood Persistent Atopic Dermatitis Managed Healthcare Executive Source link